{"id":"W4205632236","doi":"10.1177/17588359211059601","title":"Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline <i>BRCA1</i> / <i>2</i> mutations and hormone receptor status from the phase-3 BROCADE3 trial","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Medical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Aptitude Health; AbbVie","keywords":"Hazard ratio; Veliparib; Breast cancer; Metastatic breast cancer; Clinical endpoint; Placebo; BRCA mutation; Germline mutation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004757318,0.0003472524,0.001311542,0.0001001485,0.00009366125,0.00001104576,0.0001540424,0.000195196,0.0004268583],"category_scores_gemma":[0.0004842977,0.0002232459,0.00006084446,0.0007928552,0.00135639,0.0002138471,0.00006127159,0.0007249322,9.264098e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004997524,"about_ca_system_score_gemma":0.00155639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005834138,"about_ca_topic_score_gemma":0.002391572,"domain_scores_codex":[0.996232,0.0007517806,0.001138779,0.0006147613,0.0007730335,0.000489621],"domain_scores_gemma":[0.9941836,0.004485149,0.000487937,0.000306542,0.0002373655,0.0002994015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3691385,0.003796994,0.007409877,0.00009544042,0.0008220122,0.0001008754,0.003625826,0.0004179586,0.002174849,0.00009134481,0.0001067156,0.6122196],"study_design_scores_gemma":[0.8750046,0.01341814,0.0690365,0.001497107,0.001068886,0.00007965499,0.004839611,0.001581124,0.001738227,0.0009792494,0.02993872,0.0008181622],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9516782,0.03669081,0.003247328,0.005014655,0.0002580963,0.001757726,0.001219166,0.00003153278,0.0001025134],"genre_scores_gemma":[0.9517725,0.04028705,0.003316437,0.003640151,0.0001438537,0.0002893928,0.0004671649,0.00005030734,0.00003315883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6114015,"threshold_uncertainty_score":0.9103702,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.026685671906535,"score_gpt":0.392095379246344,"score_spread":0.365409707339809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}